日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

First description of a patient with Vici syndrome due to a mutation affecting the penultimate exon of EPG5 and review of the literature

MPS-Authors

Krawitz,  P.
Max Planck Society;

/persons/resource/persons50196

Hecht,  J.
Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society;

/persons/resource/persons50437

Mundlos,  S.
Research Group Development & Disease (Head: Stefan Mundlos), Max Planck Institute for Molecular Genetics, Max Planck Society;

External Resource

http://www.ncbi.nlm.nih.gov/pubmed/25331754
(全文テキスト(全般))

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

Ehmke.pdf
(出版社版), 370KB

付随資料 (公開)
There is no public supplementary material available
引用

Ehmke, N., Parvaneh, N., Krawitz, P., Ashrafi, M. R., Karimi, P., Mehdizadeh, M., Kruger, U., Hecht, J., Mundlos, S., & Robinson, P. N. (2014). First description of a patient with Vici syndrome due to a mutation affecting the penultimate exon of EPG5 and review of the literature. American Journal of Medical Genetics Part A, 164A(12), 3170-3175. doi:10.1002/ajmg.a.36772.


引用: https://hdl.handle.net/11858/00-001M-0000-0025-7851-8
要旨
Vici syndrome is a rare autosomal recessively inherited multisystem disorder characterized by agenesis of the corpus callosum, cataracts, cardiomyopathy, combined immunodeficiency, psychomotor delay, and hypopigmentation. Cullup et al. recently identified mutations in the gene EPG5 as the cause of Vici syndrome. EPG5 is involved in autophagy, an evolutionarily conserved lysosomal degradation process that is essential for cell homeostasis. Following the first description in 1988 by Vici et al., 24 other cases of Vici syndrome have been published with variable expression of the defining features. Here, we report on a further case of Vici syndrome with a homozygous truncating mutation of EPG5, identified by whole-exome sequencing. The mutation in our patient is the first reported affecting the penultimate exon of EPG5 and presenting with typical clinical manifestations of Vici syndrome. Additionally, we present a detailed clinical analysis of Vici syndrome comprising all cases previously described in the literature.